web analytics
12.6 C
Munich
Sunday, May 29, 2022

mCig Inc (OTCMKTS: MCIG) Running Up the Charts

mCig Inc (OTCMKTS: MCIG) is making a spectacular move up the charts from a start point of $0.02 on December 17 MCIG has seen recent highs near a dime.

The current run on MCIG started on January 17 after the Company announced its consumer Division (BareRoots) Received a Purchase Order for 10,000 Monthly Boxes of the Company’s Proprietary CBD-Based Products. The company anticipates revenue of approximately $1.1 Mil in its first year of operation under the agreement. It also has entered into a white labeling agreement with cannabis company to supply approximately $200,000 of CBD derivative products.

mCig Inc (OTCMKTS: MCIG) is a diversified holdings company for various subsidiaries, focusing on grow construction and cultivation, biotech, dispensary supplies, technology and consulting, payment processing, vaporizers and more, servicing the legal cannabis, hemp and CBD markets. mCig, Inc. is committed to being the leading distributor of products, services and technology to fit the needs of a rapidly expanding industry. mCig, Inc. has transitioned from a vaporizer manufacturer to industry leading large scale, full service cannabis cultivation construction company with its Grow Contractors division currently operating in the rapidly expanding Nevada market.

MCIG invested significantly in its own growth in 2018, partnering with the FarmOn!Foundation on a 40-acre hemp pilot project, NYAcres. The cultivation process will start immediately on the initial harvest of 40 acres, allowing for a second harvest in late fall. The program will expand each year over 3 years, scaling up to 120 acres of organic industrial hemp bi-annually. The success of the pilot prompted mCig to expand this model into other states. In May 2018, the company purchased land in California City and obtained licenses to grow, manufacture and distribute cannabis in the state of California, positioning itself as an early player in the recently legalized state.

Uniquely located on the corner of three states, New York, Massachusetts and Connecticut. Empire Farm is a certified organic 220-acre working farm, home to the FarmOn! Foundation, founded in 1830 and associated with the Astor family.  Nestled in an agricultural community in the heart of the Columbia County, the FarmOn! Academy is in partnership with SUNY and Cornell College of Agriculture and Life Sciences, providing young adults the opportunity to learn agriculture on an established working farm. Now home to NY Acres, Inc., the farm also offers 4 four-season heated hi-tunnel greenhouses lending its rich ‘black gold’ soil, suitable for hemp cultivation.

February, 2020 (Microcapdaily.com) — Microcapdaily.com is an exciting small caps focused media portal providing in depth content on small cap companies such as mCig Inc (OTCMKTS: MCIG).

To Find out the inside Scoop on MCIG Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

Several days ago MCIG announced the business plan for the nutraceutical joint venture of the Company and Bare Roots, Inc. BRRX Clinical will operate under two divisions, Consumer Products, and Health Care. The Consumer Products Division will operate much as most other CBD product companies, however, the emphasis will be on products with verifiable efficacy and prescribed dosages. As part of this strategy the company now has three products Registered with an FDA Institutional Review Board (IRB) in Clinical Trials. The first of these, a salve to alleviate the pain from Shingles outbreaks, was announced recently and will be available through a network of independent compounding pharmacies along with two other products also in trials.

Starting in February, the company will launch its Health Care Division. The core product for this division is a software platform developed over the past 15 years to detect an individual’s predisposition to certain diseases up to three years before symptoms reveal themselves. The platform is a GE/Intel certified program that has been in use for several years. It analyzes blood work, lab results, and genetic information to develop an individual profile that can be used to target that person for certain interventions like a change in diet, supplements or specific exercises.

The launch will start with the BRRX Clinical Subscription Service, a set of services complementing the software platform that will utilize participating clinics and doctor networks to drive consumers to get healthcare before their symptoms require more drastic medical intervention. The plan is for this to be a product marketed to employers, carriers, Physician Networks, and individuals.

On January 29 MCIG announced the opening of a new office in Scottsdale, AZ USA. This new location strengthens MCIG’s presence and offers a single location for the sales, support, and development of CBD products.

We have a Monster Pick Coming. Subscribe Right Now!

Currently trading at a $33 million market valuation MCIG has $80k in the treasury and $5.5 million in assets. When a stock like MCIG heats up investors pay attention: MCIG is one of the original post stocks on the OTC with a history of big moves including a historic run from current levels that culminated at $0.50 in January 2017. We will be updating on MCIG when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with MCIG.

Sign Up now for our 100% FREE Penny Stock Newsletter

Disclosure: we hold no position in MCIG either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.